If you are struggling to navigate the complexity of early commercialisation, rest assured, you are not alone. Clinical trial ...

AI is shooting for the moon and the stars but the real benefits come from anchoring it to the human voice Research conducted ...

Novo Nordisk has announced an investment of 8.5 billion Danish kroner, or approximately $1.2bn, to establish a new rare ...

Merck & Co – known as MSD outside the US and Canada – will be gaining exclusive global rights to Hansoh Pharma’s preclinical ...

Since the Orphan Drug Act was passed in 1983, pharmaceutical companies have increasingly focused on developing treatments for ...

In theory, the principles of omnichannel – personalised content through the right channels to maximise customer experience – ...

For most of us working in healthcare communications, the best buzz is when the work has clearly reached those who are most in ...

Gilead Sciences’ seladelpar has been recommended by the European Medicines Agency’s human medicines committee to treat the ...

Amgen’s Blincyto (blinatumomab) has been granted a licence extension by the Medicines and Healthcare products Regulatory ...

Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of ...

Approximately 121,000 people are diagnosed with primary advanced or recurrent endometrial cancer each year in Europe ...

At first glance, translating clinical outcome assessments (COAs) from their original language (most commonly English) to ...